H. Campbell

发表

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

A Briggs, J Glanville, J. Glanville, 2006, Health technology assessment.

Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement

M. Sydes, S. Halford, P. Kearns, 2020, British Journal of Cancer.

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.

P. Ellis, A. Harris, M. Sculpher, 2011, European journal of cancer.

Strengthening clinical cancer research in the United Kingdom

R. B. Hamilton, M. Parmar, D. Stewart, 2011, British Journal of Cancer.

How cost-effective is screening for abdominal aortic aneurysms?

A H Briggs, M J Buxton, S G Thompson, 2007, Journal of medical screening.

High hospital research participation and improved colorectal cancer survival outcomes: a population-based study

Amy Downing, Mahesh Parmar, David Sebag-Montefiore, 2016, Gut.

Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement

M. Sydes, S. Halford, P. Kearns, 2020, British Journal of Cancer.

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

A. Harris, A. Gray, H. Campbell, 2009, British Journal of Cancer.

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK

A. Harris, A. Briggs, A. Gray, 2010, British Journal of Cancer.

Analysis of the Comparative Effectiveness of 3 Oral Bisphosphonates in a Large Managed Care Organization: Adherence, Fracture Rates, and All-Cause Cost

J. Abarca, H. Campbell, Jingbo Yu, 2011, Journal of managed care pharmacy : JMCP.

Research-intensive cancer care in the NHS in the UK.

M. Parmar, D. Stewart, R. Wilson, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Modelling the cost-effectiveness of first, second and third generation polychemotherapy regimens in women with early breast cancer who have differing prognoses.

M. Sculpher, H. Earl, J. Yarnold, 2009 .

Extending the clinical research network approach to all of healthcare.

I. McKeith, M. Rossor, T. Wykes, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris.

L. Sharples, M. Buxton, N. Caine, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.